Sonia Molina Pinelo
Biography
|
Senior researcher of the Nicolás Monardes Programme and postdoctoral researcher at the Hospitales Universitarios Virgen del Rocío (Instituto de Biomedicina de Sevilla, IBiS) since 2017, in the Molecular and Translational Research in Oncology group. Previously, postdoctoral researcher at the Lung Cancer Clinical Research Unit of the i+12-CNIO Institute, Hospital Universitario 12 de Octubre (Madrid, 2015-2016), and in the Molecular Oncology and New Therapies research group of the Instituto de Biomedicina de Sevilla (2012-2015). Earlier, AECC postdoctoral researcher at the Medical Oncology Service of the Hospital Universitario Virgen del Rocío (from 2008), after a predoctoral fellowship of the Fundación Reina Mercedes in the Viral Hepatitis and AIDS Study Group of the same hospital (2002-2007). PhD in Biological Sciences from the University of Seville (2007), with the thesis "Immunovirological characterization of HIV-1-infected patients with discordant response to highly active antiretroviral therapy" (supervisors: Dr. Alejandro Vallejo Tiller and Dr. Manuel Leal Noval); BSc in Biochemistry (2001) and in Biological Sciences (1999) from the University of Seville. (Description curated from publicly available data.) |
Profile
| Institution | IBIS |
| Position | Senior Researcher of Nicolas Monardes Programme |
| Home page | https://www.juntadeandalucia.es/salud/alianza-andalucia-roche/es/quienes-somos/ibis-equipo-investigacion/ |
| Contact email | smolina-ibis@us.es |
| ORCID | 0000-0002-5726-2453 |
BCB Hub
| BCB Committee | Not a member |
| BCB Tools | |
| BCB Services |
Research
Research topics
Research lines
Publications 70 entries
- UGT2B17 as a predictive biomarker of complete pathological response in HER2 + breast cancer Article · 6 Mar 2026
- Interleukin‐11 promotes lung adenocarcinoma tumourigenesis and immune evasion Article · Jul 2025
- Small cell lung cancer unveiled: Exploring the untapped resource of circulating tumor cells-derived organoids Article · Mar 2025
- Telomere-based risk models for the early diagnosis of lung cancer Article · Dec 2024
- CDC7 inhibition impairs neuroendocrine transformation in lung and prostate tumors through MYC degradation Article · 26 Jul 2024
View all (65 more)
- Predictive factors for complete pathologic response in luminal breast cancer: impact of ki67 and HER2 low expression Article · Jan 2024
- Targeting the Tumor Microenvironment in Breast Cancer: Prognostic and Predictive Significance and Therapeutic Opportunities Article · 26 Nov 2023
- Landscape of tumor and immune system cells-derived exosomes in lung cancer: mediators of antitumor immunity regulation Article · 17 Oct 2023
- Inhibition of HSP90 in Driver Oncogene-Defined Lung Adenocarcinoma Cell Lines: Key Proteins Underpinning Therapeutic Efficacy Article · 7 Sep 2023
- Abemaciclib, Palbociclib, and Ribociclib in Real-World Data: A Direct Comparison of First-Line Treatment for Endocrine-Receptor-Positive Metastatic Breast Cancer Article · 9 May 2023
- MicroRNA signature and integrative omics analyses define prognostic clusters and key pathways driving prognosis in patients with neuroendocrine neoplasms Article · 5 Mar 2023
- Aberrant Methylation of the Imprinted C19MC and MIR371-3 Clusters in Patients with Non-Small Cell Lung Cancer Article · 25 Feb 2023
- Real-World Analysis of Nivolumab and Atezolizumab Efficacy in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer Article · 25 Apr 2022
- Correlation of peripheral blood biomarkers with clinical outcomes in NSCLC patients with high PD-L1 expression treated with pembrolizumab Article · Jun 2021
- Identification of Predictive Biomarkers of Response to HSP90 Inhibitors in Lung Adenocarcinoma Article · 3 Mar 2021
- Primary and Acquired Resistance to Immunotherapy in Lung Cancer: Unveiling the Mechanisms Underlying of Immune Checkpoint Blockade Therapy Article · 11 Dec 2020
- Brief Report: Toll-like Receptor 9-1635A/G Polymorphism Is Associated With HIV-1 Rebound After Four Weeks of Interruption of Antiretroviral Therapy Article · 1 Oct 2020
- The Roles of Imprinted SLC22A18 and SLC22A18AS Gene Overexpression Caused by Promoter CpG Island Hypomethylation as Diagnostic and Prognostic Biomarkers for Non-Small Cell Lung Cancer Patients Article · 27 Jul 2020
- MicroRNAs as potential predictors of extreme response to tyrosine kinase inhibitors in renal cell cancer Article · Jul 2020
- FGFR1 and FGFR4 oncogenicity depends on n-cadherin and their co-expression may predict FGFR-targeted therapy efficacy Article · Mar 2020
- Epigenetics of lung cancer: a translational perspective Article · 8 Aug 2019
- Impact of Heat Shock Protein 90 Inhibition on the Proteomic Profile of Lung Adenocarcinoma as Measured by Two-Dimensional Electrophoresis Coupled with Mass Spectrometry Article · 31 Jul 2019
- A patent review of FGFR4 selective inhibition in cancer (2007-2018) Article · 30 May 2019
- FGFR4 increases EGFR oncogenic signaling in lung adenocarcinoma, and their combined inhibition is highly effective Article · May 2019
- FGFR1 Cooperates with EGFR in Lung Cancer Oncogenesis, and Their Combined Inhibition Shows Improved Efficacy Article · Apr 2019
- Long non-coding RNAs as monitoring tools and therapeutic targets in breast cancer Article · 25 Oct 2018
- MAP17 predicts sensitivity to platinum-based therapy, EGFR inhibitors and the proteasome inhibitor bortezomib in lung adenocarcinoma Article · 17 Aug 2018
- Corrigendum to “Tyrosine Kinase Receptor Landscape in Lung Cancer: Therapeutical Implications” Article · 19 Jul 2018
- Corrigendum to “Proteomic-Based Approaches for the Study of Cytokines in Lung Cancer” Article · 8 Jul 2018
- Histology-dependent prognostic role of pERK and p53 protein levels in early-stage non-small cell lung cancer Article · 13 Apr 2018
- The FGFR4-388arg Variant Promotes Lung Cancer Progression by N-Cadherin Induction Article · 5 Feb 2018
- Single nucleotide polymorphisms as prognostic and predictive biomarkers in renal cell carcinoma Article · 20 Nov 2017
- Prognostic Role of the FGFR4-388Arg Variant in Lung Squamous-Cell Carcinoma Patients With Lymph Node Involvement Article · Nov 2017
- Coordinated downregulation of Spinophilin and the catalytic subunits of PP1, PPP1CA/B/C, contributes to a worse prognosis in lung cancer Article · 26 Oct 2017
- Biological therapies in nonsmall cell lung cancer Article · Mar 2017
- IL-11 and CCL-1: Novel Protein Diagnostic Biomarkers of Lung Adenocarcinoma in Bronchoalveolar Lavage Fluid (BALF) Article · Dec 2016
- Numb-like (NumbL) downregulation increases tumorigenicity, cancer stem cell-like properties and resistance to chemotherapy Article · 23 Aug 2016
- Analysis of the immune microenvironment in resected non-small cell lung cancer: the prognostic value of different T lymphocyte markers Article · 24 Jul 2016
- Current Challenges in Cancer Treatment Article · Jul 2016
- 20P Context-dependent role of FGFR4 in lung tumorogenesis Article · Apr 2016
- 19P Comparative effectiveness analysis of HSP90 inhibitors in non-small cell lung cancer Article · Apr 2016
- Tyrosine Kinase Receptor Landscape in Lung Cancer: Therapeutical Implications Article · 2016
- Proteomic-Based Approaches for the Study of Cytokines in Lung Cancer Article · 2016
- Gene expression profile predictive of response to chemotherapy in metastatic colorectal cancer Article · 30 Jan 2015
- MiR-107 and miR-99a-3p predict chemotherapy response in patients with advanced colorectal cancer Article · 7 Sep 2014
- MicroRNA clusters: dysregulation in lung adenocarcinoma and COPD Article · 17 Apr 2014
- MicroRNA-Dependent Regulation of Transcription in Non-Small Cell Lung Cancer Article · 13 Mar 2014
- VeriStrat: a prognostic and/or predictive biomarker for advanced lung cancer patients? Article · 3 Dec 2013
- Identification of proteomic signatures associated with lung cancer and COPD Article · Aug 2013
- Spinophilin Loss Correlates with Poor Patient Prognosis in Advanced Stages of Colon Carcinoma Article · 15 Jul 2013
- Proteomic biomarkers in lung cancer Article · 20 Apr 2013
- Identification of Oxidative Stress Related Proteins as Biomarkers for Lung Cancer and Chronic Obstructive Pulmonary Disease in Bronchoalveolar Lavage Article · 6 Feb 2013
- PDGFRα/β and VEGFR2 polymorphisms in colorectal cancer: incidence and implications in clinical outcome Article · 12 Nov 2012
- Down‐regulation of spinophilin in lung tumours contributes to tumourigenesis Article · 19 May 2011
- Premature immunosenescence in HIV-infected patients on highly active antiretroviral therapy with low-level CD4 T cell repopulation Article · 16 Jul 2009
- HCV RNA in peripheral blood cell subsets in HCV–HIV coinfected patients at the end of PegIFN/RBV treatment is associated with virologic relapse Article · 18 Dec 2008
- The absence of HCV RNA in peripheral blood cell subsets at the end of PegIFN/RBV treatment is associated with virologic sustained response in HCV-HIV coinfected patients Poster · 19 Jun 2008
- HIV–hepatitis C virus co-infection is associated with decreased plasmatic IL-7 levels Article · 11 Jan 2007
- Immunovirologic Characteristics of Human Immunodeficiency Virus-Infected Patients Consisting Mainly of Injecting Drug Users on Highly Active Antiretroviral Treatment with Prolonged Virologic Failure Article · Dec 2006
- Thymic Volume Predicts CD4 T-Cell Decline in HIV-Infected Adults Under Prolonged Treatment Interruption Article · Jun 2006
- Thymic Function-Related Markers Within the Thymus and Peripheral Blood: Are They Comparable? Article · Jan 2006
- Prevalence and factors involved in discordant responses to highly active antiretroviral treatment in a closely followed cohort of treatment-naïve HIV-infected patients Article · Jun 2005
- Effect of Hepatitis C Virus Coinfection on Humoral Immune Alterations in Naïve HIV-Infected Adults on HAART: A Three Year Follow-Up Study Article · May 2005
- Factors involved in CD4 cell count lost in HIV-infected patients on treatment interruption driven by CD4 Poster · 1 Dec 2004
- Analysis of quasispecies in the viral 5′ untranslated region of hepatitis C virus to evaluate ribavirin mutagenic effect in patients receiving ribavirin and interferon-alfa Article · 17 Nov 2004
- High thymic volume and output at baseline is associated with enhancement of viral replication and immunologic impairment early after HAART discontinuation in chronic HIV infection Poster · 3 Jun 2004
- Role of the hepatitis C virus-coinfection on humoral immune alterations in HIV-infected patients on HAART Conference paper · 3 Jun 2004
- Thymic volume is independently associated with the magnitude of CD4+ T-cell recovery after short and long term on HAART Conference paper · 1 Jul 2003
- Evolution of hepatitis C virus quasispecies in infected-patients receiving IFN-α and ribavirin Poster · 28 Mar 2003
- Thymic function is impaired in adult hepatitis C virus co-infected patients on HAART Poster · 28 Mar 2003
